Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
P A Cassier, A Lefranc, E Y Amela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
A Italiano, M Toulmonde, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 12, 2013
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group
A Gronchi, C Colombo, C Le Péchoux, et al.
ESMO Open
|
June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network
A Smrke, A M Frezza, C Giani, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial
J-Y Blay, Q Devin, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
P A Cassier, A Lefranc, E Y Amela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
A Italiano, M Toulmonde, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 12, 2013
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group
A Gronchi, C Colombo, C Le Péchoux, et al.
ESMO Open
|
June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network
A Smrke, A M Frezza, C Giani, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
P Pautier, N Penel, I Ray-Coquard, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 30, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial
J-Y Blay, Q Devin, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
Page
of 8